Osteocalcin: A new link between bone and energy metabolism. Some evolutionary clues

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 14, Issue 4, 2011, Pages 360-366

  Fernández Real, Jose M ^a,b   Ricart, Wifredo ^a  

^a Instituto de Salud Carlos III   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

insulin sensitivity; obesity; osteocalcin; type 2 diabetes

Indexed keywords

ADIPONECTIN; CALCIUM; GLUCOSE; INSULIN; INSULIN RECEPTOR; LEPTIN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ACROMEGALY; ADIPOCYTE; AEROBIC EXERCISE; BODY MASS; BONE CELL; BONE DENSITY; BONE METABOLISM; BONE REMODELING; CALCIUM SIGNALING; CALCIUM TRANSPORT; CARBOHYDRATE METABOLISM; CARDIOVASCULAR RISK; CYCLING; DRUG ACTIVITY; ENERGY EXPENDITURE; ENERGY METABOLISM; EXERCISE; EXTRACELLULAR CALCIUM; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; IN VITRO STUDY; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; JUMPING; KIDNEY FAILURE; LIPID BLOOD LEVEL; LIPOGENESIS; LIVER FUNCTION; LIVER INJURY; MOLECULAR WEIGHT; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PHYSICAL ACTIVITY; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANIMALS; BIOLOGICAL EVOLUTION; BONE AND BONES; CARBOHYDRATE METABOLISM; ENERGY METABOLISM; HUMANS; INSULIN; INSULIN RESISTANCE; KIDNEY DISEASES; LEPTIN; LIVER; MOTOR ACTIVITY; OSTEOBLASTS; OSTEOCALCIN;

EID: 79959208070     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328346df4e     Document Type: Review

References (39)

1. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006; 55:1537-1545. (Pubitemid 44324105)
2. Currey JD. How well are bones designed to resist fracture? J Bone Miner Res 2003; 18:591-598. (Pubitemid 36899308)
3. Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000; 100:197-207. (Pubitemid 30064908)
4. Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007; 130:456-469. (Pubitemid 47208519)
5. Ferron M, Wei J, Yoshizawa T, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010; 142:296-308.
6. Fulzele K, Riddle RC, DiGirolamo DJ, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010; 142:309-319.
7. Clemens TL, Karsenty G. The osteoblast: an insulin target cell controlling glucose homeostasis. J Bone Miner Res 2011; 26:677-680.
8. Confavreux CB, Levine RL, Karsenty G. A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol Cell Endocrinol 2009; 310:21-29.
9. Lee NK, Karsenty G. Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metab 2008; 19:161-166. (Pubitemid 351847838)
10. Fernandez-Real JM, Izquierdo M, Ortega F, et al. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 2009; 94:237-245.
11. Im JA, Yu BP, Jeon JY, Kim SH. Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chim Acta 2008; 396:66-69.
12. Kanazawa I, Yamaguchi T, Yamamoto M, et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009; 94:45-49.
13. Pittas AG, Harris SS, Eliades M, et al. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 2009; 94:827-832.
14. Kindblom JM, Ohlsson C, Ljunggren O, et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res 2009; 24:785-791.
15. Shea MK, Gundberg CM, Meigs JB, et al. g-Carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr 2009; 90:1230-1235.
16. Zhou M, Ma X, Li H, et al. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J Endocrinol 2009; 161:723-729.
17. Hwang YC, Jeong IK, Ahn KJ, Chung HY. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced b-cell function in middle-aged male subjects. Diabetes Metab Res Rev 2009; 25:768-772.
18. Winhofer Y, Handisurya A, Tura A, et al. Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diabetes Care 2010; 33:139-143.
19. Kanazawa I, Yamaguchi T, Yamauchi M, et al. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int 2011; 22:187-194.
20. Motyl KJ, McCabe LR, Schwartz AV. Bone and glucose metabolism: a twoway street. Arch Biochem Biophys 2010; 503:2-10.
21. Sucunza N, Barahona MJ, Resmini E, et al. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly. J Clin Endocrinol Metab 2009; 94:3889-3896.
22. Villareal DT, Fontana L, Weiss EP, et al. Bone mineral density response to caloric restriction-induced weight loss or exercise-induced weight loss. Arch Intern Med 2006; 166:2502-2510. (Pubitemid 44913236)
23. Levinger I, Zebaze R, Jerums G, et al. The effect of acute exercise on undercarboxylated osteocalcin in obese men. Osteoporos Int 2010. [Epub ahead of print]
24. Guadalupe-Grau A, Ara I, Dorado C, et al. Osteocalcin as a negative regulator of serum leptin concentration in humans: insight from triathlon competitions. Eur J Appl Physiol 2010; 110:635-643.
25. Larson-Meyer DE, Newcomer BR, Heilbronn LK, et al. Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity 2008; 16:1355-1362. (Pubitemid 351770499)
26. Fernández-Real JM, Ortega F,Gómez-Ambrosi J, et al. Circulating osteocalcin concentrations are associated with parameters of liver fat infiltration and increase in parallel to decreased liver enzymes after weight loss. Osteoporos Int 2010; 21:2101-2107.
27. Diamond TH, Stiel D, Lunzer M, et al. Hepatic osteodystrophy static and dynamic bone histomorphometry and bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 2008; 96:213-221.
28. Foresta C, Strapazzon G, De Toni L, et al. Evidence for osteocalcin production by adipose tissue and its role in human metabolism. J Clin Endocrinol Metab 2010; 95:3502-3506.
29. Reinehr T, Roth CL. A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss. Int J Obes 2010; 34:852-858.
30. Prats-Puig A, Mas-Parareda M, Riera-Pérez E, et al. Carboxylation of osteocalcin affects its association with metabolic parameters in healthy children. Diabetes Care 2010; 33:661-663.
31. Yamada S, Inaba M, Kurajoh M, et al. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction. Clin Endocrinol 2008; 69:189-196. (Pubitemid 352009021)
32. Das SK, Sharma NK, Elbein SC. Analysis of osteocalcin as a candidate gene for type 2 diabetes (T2D) and intermediate traits in Caucasians and African Americans. Dis Markers 2010; 28:281-286.
33. Nesse RM, Bergstrom CT, Ellison PT, et al. Evolution in health and medicine Sackler colloquium: making evolutionary biology a basic science for medicine. Proc Natl Acad Sci USA 2010; 107 (Suppl 1):1800-1807.
34. Wu H, Peisley A, Graef IA, Crabtree GR. NFAT signaling and the invention of vertebrates. Trends Cell Biol 2007; 17:251-260. (Pubitemid 46829850)
35. Heit JJ, Apelqvist AA, Gu X, et al. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature 2006; 443:345-349. (Pubitemid 44435154)
36. Fernández-Real JM, Pickup JC. Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2008; 19:10-16.
37. Green DR, Wang R. Calcium and energy: making the cake and eating it too? Cell 2010; 142:200-202.
38. Szulc P, Delmas PD. Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. Osteoporos Int 2008; 19:1683-1704.
39. Tran GT, Pagkalos J, Tsiridis E, et al. Growth hormone: does it have a therapeutic role in fracture healing? Expert Opin Investig Drugs 2009; 18: 887-911.